Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)
Clinical trial NCT02615145 · COMPLETED
Trial details
- NCT number
- NCT02615145
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-03
- Primary completion
- 2018-03-26
- Enrollment
- 472
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.